Cleared Traditional

K102617 - AUDIT MICROCV CARDIAC MARKERS LINEARITY SET

K102617 is an FDA 510(k) clearance for AUDIT MICROCV CARDIAC MARKERS LINEARITY SET, manufactured by Aalto Scientific, Ltd.. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 122-day FDA review.

K102617 · Aalto Scientific, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
122d
Days
Class 1
Risk

K102617 is an FDA 510(k) clearance for the AUDIT MICROCV CARDIAC MARKERS LINEARITY SET. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Aalto Scientific, Ltd. (Carlsbad, US). The FDA issued a Cleared decision on January 10, 2011 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Aalto Scientific, Ltd. devices

FDA 510(k) Submission Details - K102617

510(k) Number K102617 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2010
Decision Date January 10, 2011
Days to Decision 122 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 88d · This submission: 122d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 572
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K102617.
MISSION CLINICHECK ASSAYED CHEMISTRY CONTROLS, LEVEL 1, LEVEL 2, DUAL LEVEL
K103364 · Diamond Diagnostics, Inc. · May 2011
MSC LIPID CONTROL
K103271 · Maine Standards Co. · Jan 2011
AUDIT MICROCV PROTEIN LINEARITY SET
K101216 · Aalto Scientific, Ltd. · Jan 2011
FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROL MODEL 108-20
K101809 · Fujirebio Diagnostics,Inc. · Oct 2010
AUDIT MICROCV AMMONIAN/ETHANOL LINEARITY SET, MODEL K712M-5
K100718 · Aalto Scientific, Ltd. · Sep 2010
PRECICONTROL CLINCHEM MULTI 1 AND 2
K102016 · Roche Diagnostics · Sep 2010